SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 878.62 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 11,153.04 |
Book Value / Share | 12.06 |
Price / Book | n/a |
NCAV ($M) | -160.93 |
NCAV / Share | -0.17 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.09 |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 0.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.48 |
Current Ratio | 1.81 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 12,194.28 |
Assets | 23,508.26 |
Liabilities | 12,355.22 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
GLUC – Glucose Health, Inc. | GNCAQ – Genocea Biosciences, Inc. |
GNFTF – Genfit S.A. | GNMSF – Genmab A/S |
GNTLF – Genetic Technologies Limited |
Financial data and stock pages provided by
Fintel.io